{"id":"W3137618571","doi":"10.1007/s00280-021-04249-7","title":"Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)","year":2021,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Janssen Research and Development","keywords":"Medicine; Prostate cancer; Abiraterone acetate; Internal medicine; Prednisone; Enzalutamide; Adverse effect; Oncology; Pharmacokinetics; Urology; Discontinuation; Androgen receptor; Cancer; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001630799,0.0003565185,0.000617534,0.0001127309,0.0001523835,0.00003761382,0.00007235835,0.00006253694,0.001006653],"category_scores_gemma":[0.000004692936,0.000244468,0.00003131036,0.0004644913,0.0002360467,0.0001373198,0.00002445058,0.0003168024,9.31014e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002046589,"about_ca_system_score_gemma":0.0006235766,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009479666,"about_ca_topic_score_gemma":0.0004699596,"domain_scores_codex":[0.9978651,0.0002128702,0.0004000239,0.0007491396,0.0003238436,0.0004490283],"domain_scores_gemma":[0.9990008,0.0001160737,0.0001626182,0.0001758674,0.000288426,0.0002562396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3184127,0.00775733,0.4504248,0.0001710374,0.004268403,0.0005860746,0.01364359,0.00005623534,0.08406696,0.000001441889,0.00101205,0.1195993],"study_design_scores_gemma":[0.5717832,0.0130386,0.1999819,0.0002975267,0.0008977877,0.00001692075,0.001591565,0.0002890063,0.1951334,0.0000150718,0.01619798,0.0007569597],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808801,0.0127878,0.000003529802,0.002180696,0.0001373468,0.002482258,0.00144914,0.00003133635,0.00004773576],"genre_scores_gemma":[0.965591,0.03165261,0.0001497783,0.001097043,0.0001136231,0.0004472159,0.0005562893,0.00004908701,0.0003433303],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2533705,"threshold_uncertainty_score":0.9999065,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02511711121625155,"score_gpt":0.3428742125230949,"score_spread":0.3177571013068433,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}